Business News
Home > Business News
Pharma companies lead topline growth in Q1FY22
TIWN
TIWN
PHOTO : TIWN
Mumbai, Aug 23 (TIWN) Corporate earnings for April-June were robust despite the second wave of Covid-19 and a report by ICICI Direct Research showed that the topline growth during the quarter was led by pharmaceutical companies.
Corporate earnings for April-June were robust despite the second wave of COVID-19 and a report by ICICI Direct Research showed that the topline growth during the quarter was led by pharmaceutical companies.
Add your Comment
Comments (0)
More Business News
- IMF expects India to rev up global growth as China falters, backs Modi government's economic policies
- realme set to shake up market: Launching fastest entry-level 5G smartphone 'C65' under Rs 10k
- India's industrial production accelerates to 5.7pc in Feb
- India records 17 pc jump to become 4th largest exporter of digital services: WTO report
- 300 pc rise in market cap to Rs 400 lakh crore in last 10 years driven by strong economic fundamentals
Special Articles
Sanjay Majumder
Anirban Mitra